systematic review bpc-157 human evidence The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Gastric pentadecapeptide body protection compound
Description
BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review
discontinue if serious reactions occur
: B-12 B-12 B-12 : B-12
While BPC-157 derives from a protective protein found in gastric juice, TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide present in almost all human cells
